RBEL1 is required for osteosarcoma cell proliferation via inhibiting retinoblastoma 1

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Osteosarcoma is the most common primary bone cancer.
• The molecular mechanisms driving osteosarcoma cell proliferation remain largely unknown.

Purpose of the Study:

• To investigate the role of RBEL1, a novel Rab-like GTPase, in regulating osteosarcoma cell proliferation.
• To elucidate the molecular pathway through which RBEL1 influences osteosarcoma progression.

Main Methods:

• RBEL1 was knocked down in osteosarcoma cells.
• Cell proliferation, colony formation, and cell cycle progression were analyzed.
• Western blotting was used to assess protein expression levels of Rb and its downstream targets.

Main Results:

• RBEL1 knockdown significantly impaired osteosarcoma cell proliferation and colony formation.
• RBEL1 depletion induced G1-S cell cycle arrest.
• RBEL1 knockdown led to upregulation and activation of retinoblastoma 1 (Rb), with downregulation of Rb targets like cyclin A2, cyclin D1, c-Myc, and CDK2.
• Knockdown of Rb reversed the tumor-suppressive effects of RBEL1 depletion.

Conclusions:

• RBEL1 acts as a key regulator of osteosarcoma cell proliferation by inhibiting Rb.
• RBEL1 plays a critical role in controlling the G1-S transition in osteosarcoma cells.
• RBEL1 represents a potential therapeutic target for osteosarcoma treatment.